Evidence-based toxicology: "Sound science" in new disguise

International Journal of Occupational and Environmental Health

Volumn 14, Issue 4, 2008, Pages 299-306

  Rudén, Christina ^a,b   Hansson, Sven Ove ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b Department of Philosophy ^*  (Sweden)

Author keywords

Bias; Burden of proof; Evidence based medicine; Evidence based toxicology; Philip Morris; Philip S. Guzelian; Risk assessment; Sound science; Tobacco

Indexed keywords

CARCINOGENICITY; EVIDENCE BASED MEDICINE; EVIDENCE BASED TOXICOLOGY; EXPOSURE; HEALTH HAZARD; NOTE; PRIORITY JOURNAL; TOBACCO INDUSTRY; TOXICOLOGY;

EID: 56549091509     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2008.14.4.299     Document Type: Note

References (33)

1. Hoffmann S, Hartung T. Toward an evidence-based toxicology. Hum Exp Toxicol. 2006;25:497-513.
2. EBT: Evidence-based Toxicology. Italy. [cited 2008] Available from: www.ebtox.org.
3. Guzelian PS, Victoroff MS, Halmes NC, et al. Evidence-based toxicology: a comprehensive framework for causation. Hum Exp Toxicol. 2005;24:161-201.
4. U.S. Environmental Protection Agency. Guidelines for Carcinogen Risk Assessment. Risk Assessment Forum Washington, DC EPA/630/P-03/001F, March 2005. [cited 2008] (Available from: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm? deid=116283).
5. International Agency for Research on Cancer (IARC) Preamble to their Monographs. .[cited 2008] Available from www.iarc.fr
6. National Toxicology Programme's 11th Report on Carcinogens. [cited 2008] Available from;ntp.niehs.nih.gov
7. Carbone M, Klein G, Gruber J, Wong M. Modern Criteria to Establish Human Cancer Etiology. Cancer Res. 2004;64:5518-5524.
8. Hill AB. The Environment and Disease: Association or Causation? Proc R Soc Med. 1965;58:295-300 (p. 299).
9. Taubes G. Epidemiology faces its limits. Science. 1995;269:164-9.
10. Wynder EL. Invited Commentary. Response to Science Article, 'Epidemiology Faces Its Limits'. Am J Epidemiol. 1996;143:747-749.
11. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years'observations on male British doctors. BMJ. 2004;328:1519. (Table 1, p.3)
12. NRC, National Research Council. Risk assessment in the federal government - Managing the process, National Academy Press; 1983.
13. NRC, National Research Council. Science and judgement in risk assessment. Committee on risk assessment of hazardous air pollutants, Commission on life sciences, NRC Washington DC, National Academy Press; 1994.
14. European Commission. Technical Guidance Document on Risk Assessment in support of Commission Directive 93/67/EEC on Risk Assessment for new notified substances Commission Regulation (EC) No 1488/94 on Risk Assessment for existing substances Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market 2003. [cited 2008] Available from:ecb.jrc.it
15. U.S. Environmental Protection Agency. Guidelines for Carcinogen Risk Assessment. Risk Assessment Forum Washington, DC EPA/630/P-03/001F, March 2005. [cited 2008] (Available from: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm? deid=116283).
16. Shelby MD. National Toxicology Program Center for the Evaluation of Risks to Human Reproduction: Guidelines for CERHR Expert Panel Members Birth Defects Research (Part B) 2005;74:9-16. [cited 2008] Available from: http://cerhr.niehs.nih.gov/reports/journal/CERHRguidelines.pdf
17. Meek ME, Bucher JR, Cohen SM, et al. A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action. Crit Rev Toxicol. 2003;33:591-653.
18. Boobis AR, Cohen SM, Dellarco V, et al. IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans. Crit Rev Toxicol. 2006;36:781-792.
19. Commission Directive 2001/59/EC of 6 August 2001adapting to technical progress for the 28th time Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances Official Journal of the European Communities L 225/1 21.8.2001.
20. Commission Directive 2003/63/EC on Community code relating to medicinal products for human use (EC, 2003a) amends Directive 2001/83, Annex I.
21. Tomatis L, Melnick RL, Haseman J, et al. Alleged 'misconceptions' distort perceptions of Environmental cancer risks. FASEB J. 2001;15:195-203.
22. Herrington DM, Howard TD. From Presumed Benefit to Potential Harm - Hormone Therapy and Heart Disease. N Engl J Med. 2003;349:519-521.
23. Bucher JR. The National Toxicology Program Rodent Bioassay. Ann N Y Acad Sci. 2002;982:198-207.
24. Olson H, Graham B, Robinson D, et al. Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals. Regul Toxicol Pharmacol. 2000;32:56-67.
25. See, for example, Mooney C. The Fraud of 'Sound Science." Gadflyer. 2004 May 13. Available from: www.alternet.org/Story/18696.
26. It is interesting to note that Guzelian et al pay a tribute to judge Osteen's criticism of EPA's 1993 report "Respiratory Health Effects of Passive Smoking" in which EPA concluded that environmental tobacco smoke is a carcinogen (p. 171). They do not however mention that judge Osteen is a former tobacco lobbyist or that massive evidence obtained in the years after EPA's 1993 report showed that EPA was right. Neither do they share the information that Osteen's judgment was appealed to the United States Court of Appeals and dismissed on technical grounds (http://www.ocat.org/opposition/ industry_campaigns.html). Both IARC and NTP have declared environmental tobacco smoke as being carcinogenic to humans (See www.iarc.fr, National Toxicology Programme's 11th Report on Carcinogens [ntp.niehs.nih.gov].) Judge Osteen's criticism is available at: http://www.tobacco.org/Documents/980717osteen.html.
27. Ong EK, Glantz AS. Constructing "sound science" and "good epidemiology": Tobacco, lawyers, and public relations firms. Am J Public Health. 2001;91:1749-1757.
28. Documents relating to Guzelian's involvement with the tobacco industry [cited 2008]. Available from: http://tobaccodocuments.org/profiles/ guzelian_philip.html, http://legacy.library.ucsf.edu and http:// tobaccodocuments.org.
29. Deposition of Philip S. Guzelian in the case of Jesus Delaluz v. Safety-Kleen Corporation, et al.., Superior Court of the State of California for the County of Los Angeles, May 13, 2000.
30. Trial Testimony of Philip S. Guzelian in the case of Jesus Delaluz v. Safety-Kleen Corporation, et al., Superior Court of the State of California for the County of Los Angeles, June 8, 2000.
31. Atlantic Legal Foundation. Atlantic Legal News Archive. [cited 2008] Available from: http://www.atlanticlegal.org/newsitem.php?nid=40.
32. Atlantic Legal Foundation. Sound Science. [cited 2008] Available from: http://www.atlanticlegal.org/program.php?catid=2.
33. Deposition Of Philip S. Guzelian, Jr., M.D. Cause No. 96-Cvq01439-D3; Manuela Navarro, vs. Missouri Pacific Railroad Company D/B/A Union Pacific Railroad Company, et al. 341st Judicial District Court, Webb County, Texas May 28, 1999.